ArticleAmerican journal of cancer research2020

Shikonin enhances the antitumor effect of cabazitaxel in prostate cancer stem cells and reverses cabazitaxel resistance by inhibiting ABCG2 and ALDH3A1.

Lili Wang et al.PubMed ↗Full text ↗

No numbers read from the abstract.